NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Drug Approval Remove constraint Subjects: Drug Approval Publication Year 2020 to 2021 Remove constraint Publication Year: <span class="from" data-blrl-begin="2020">2020</span> to <span class="to" data-blrl-end="2021">2021</span>

Search Results

24. Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment